Introduction: Normal Cell Metabolism

Cellular respiration describes the series of steps that cells use to break down sugar and other  chemicals to get the energy we need to function.  Energy is stored in the bonds of glucose (like a stretched rubber band), and when glucose is broken down, much of that energy is released.  Some of it is captured in a form that can be used to do work in cells - a molecule called adenosine triphosphate or ATP. The energy that is not captured in ATP is usually given off as heat (one of the things that helps us maintain our normal body temperature).

The process of cellular respiration is similar to a car using gasoline as fuel.  As gasoline is the fuel for a car, glucose is the fuel for a cell. A car burns gasoline and uses the energy released for movement. Similarly, a cell ‘burns’ glucose to capture the energy and create ATP. ATP is the primary form of energy that cells use to function.

The first step of respiration is called glycolysis. In a series of steps, glycolysis breaks glucose into two smaller molecules - a chemical called pyruvate. A small amount of ATP is also formed during this process. The process can be likened to a waterslide. A person has more energy at the top and loses it as they slide down.

Most healthy cells continue the breakdown in a second process, called the Kreb's cycle. The Kreb's cycle allows cells to “burn” the pyruvates made in glycolysis to get more ATP.

glycolysis and Kreb's cycle

The last step in the breakdown of glucose is called oxidative phosphorylation (Ox-Phos). It takes place in specialized cell structures called mitochondria. This process produces a large amount of ATP.  Importantly, cells need oxygen to complete oxidative phosphorylation. If a cell completes only glycolysis,only 2 molecules of ATP are made per glucose. However, if the cell completes the entire respiration process (glycolysis - Kreb's - oxidative phosphorylation), about 36 molecules of ATP are created, giving it much more energy to use. Further information on the topics on this page can also be found in most introductory Biology textbooks, we recommend Campbell Biology, 11th edition.1

Topics on this Page:

What Cancer Cells Do Differently

Unlike healthy cells that "burn" the entire molecule of sugar to capture a large amount of energy as ATP, cancer cells are wasteful. Cancer cells only partially break down sugar molecules. They overuse the first step of respiration, glycolysis. They frequently do not complete the second step, oxidative phosphorylation. This results in only 2 molecules of ATP per each glucose molecule instead of the 36 or so ATPs healthy cells gain. As a result, cancer cells need to use a lot more sugar molecules to get enough energy to survive. 2

Otto Warburg, a German scientist, was the first to describe this unusual behavior of cancer cells. He won the Nobel Prize in 1931 for his work. He noticed that cancer cells only complete glycolysis (and NOT Ox-Phos), even when oxygen is present (a process called aerobic glycolysis). The presence of oxygen should allow them to complete the entire process of respiration. An abnormal dependence on glycolysis as the sole source of ATP creation, even in the presence of oxygen is seen in many cancer cells and is commonly called the 'Warburg effect'. 3

Some cancer cells may not be able to complete the entire respiration process due to defects caused by changes in their DNA (mutations), but that is not the whole story. Using only glycolysis may provide cancer cells with some advantages. The products of glycolysis (bicarbonic acid and lactic acid) may be used to build products that help cancer cells to survive and grow.

Research has also suggested that using aerobic glycolysis may help cancer cells avoid being recognized and killed by cells of the immune system. 2 Changes in the metabolic environment may block immune cells from finding cancer cells and even attract cells that may help tumor cells to grow. The unusual metabolic changes seen in cancer cells may also activate oncogenes that allow the cancer cells to avoid death.


Otto Warburg


Hypoxia and the Tumor Environment

The environment within a tumor is stressful for the normal cells living there. The blood vessels (vasculature) in a tumor are not formed properly and are often twisted and abnormal (convoluted) looking. The defective structure leads to a poor ability to deliver oxygen and results the development acidic conditions. Another result of the abnormal vessel distribution is that some parts of the tumor are far from blood vessels and do not receive enough nutrients and oxygen. 4 As tumors grow in size, they can outgrow their blood supply. This results in the area inside the tumor becoming very low in oxygen (hypoxic). Cells that only use glycolysis are not dependent on oxygen for survival. This may benefit cancer cells that are in environments low in oxygen.

In response to hypoxic conditions (aka. hypoxia), a protein called hypoxia induced factor 1-alpha (HIF1-α) is activated. The HIF1-α protein increases the rate of glycolysis and decreases the conversion of glucose to the products seen in normal cells. 5 Hypoxia and HIF1-α activation cause problems. Low oxygen levels help to promote cell movement and cancer spread (metastasis) by causing the production of TWIST, a protein that plays an essential role in metastasis. TWIST activation results in cancer cells loosening their grip on their surroundings, allowing them to move and invade nearby tissues. The process by which epithelial cells change into a type of cell that is able to move more easily is known as the epithelial-mesenchymal transition (EMT). Along with the ability to move, the EMT gives the cells additional ‘primitive’ capabilities that help protect the cancer cells and enhance the spread of cancer. 6


Genetic Changes and Cancer Cell Metabolism

Many DNA changes (mutations) occur in cancer cells that are not present in healthy cells. Some of these changes can lead to increased glycolysis. AKT, an oncogene involved in cell metabolism and survival, can be activated in response to hypoxia and HIF1-α. This can lead to increased survival of cancer cells. 5 Other oncogenes, RAS and MYC, are often activated in cancer cells. Their proteins both contribute to the aerobic glycolysis seen in cancer cells. 7

In cancer cells, tumors suppressors that stop cancer cell growth and lead to cell death are often inactivated. The loss of the tumor suppressor p53 can trigger the Warburg effect and cells becoming "addicted" to glycolysis. 4

Aerobic glycolysis is also linked to the production/activity of another protein, the vascular endothelial derived growth factor (VEGF). VEGF causes blood vessel formation (angiogenesis). Tumors need to create new blood vessels to retain a nutrient supply as they grow. The abnormal metabolism seen in cancer cells may drive the creation of new blood vessels. 8

Researchers recently discovered another way that cancer cells produce the products they need to survive. The mitochondria in the cells use lactate to grow and fuel reactions. Multiple experiments were done on individual mitochondria in cancer cells, and the results confirmed that lactate is getting into the mitochondria and being used to create nutrients for the cancer cell.9

Metabolism in Tumor Detection and Treatment

As mentioned, cancer cells often undergo aerobic glycolysis, a very inefficient way to obtain ATP. Cancer cells must therefore use a lot more glucose to generate enough ATP to survive. Positron emission tomography (PET) is a detection method that takes advantage of this situation to detect cancer. In PET imaging, patients are injected with a chemical, fluorodeoxyglucose (FDG) that is very similar to glucose. The presence of FDG in tissues can be detected by a PET machine. Tumors demonstrate an increased glucose and FDG uptake compared to normal tissue. PET can be used to stage tumors, assess responses to treatment, predict aggressiveness of tumors, and help to predict patient outcomes. 10

Cancer cell metabolism also provides clues to possible targets of treatment. Dichloroacetate (DCA) is a chemical that is being tested for its ability to reactivate Ox-Phos in tumor cells and suppress their growth. 11 Clinical trials are also examining the use of drugs that block glycolysis.

PET Scan Machine
  • 1. Urry, L. A., Cain, M. L., Wasserman, S. A., Minorsky, P. V., & Reece, J. B. (2017). Campbell Biology (11th ed.). Pearson.
  • 2. a. b. Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell. 2008 Jun;13(6):472-82. [PUBMED]
  • 3. Warburg, O. On the origin of cancer cells. Science. 1956 Feb 24;123(3191):309-14. [PUBMED]
  • 4. a. b. Denko NC. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer. 2008 Sep;8(9):705-13. [PUBMED]
  • 5. a. b. Kaelin WG Jr, Thompson CB. Q&A: Cancer: clues from cell metabolism. Nature. 2010 Jun 3;465(7298):562-4. [PUBMED]
  • 6. Wu KJ, Yang MH. Epithelial-mesenchymal transition and cancer stemness: the Twist1-Bmi1 connection. Biosci Rep. 2011 Dec;31(6):449-55. [PUBMED]
  • 7. Singleterry J, Sreedhar A, Zhao Y. Components of cancer metabolism and therapeutic interventions. Mitochondrion. 2014 Jul;17:50-5. [PUBMED]
  • 8. Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell. 2008 Sep 5;134(5):703-7. [PUBMED]
  • 9. NCI Staff. "Metabolomics Study Reveals another Energy Source for Cancer Cells ." NIH National Cancer Institute. (2017). [NCI]
  • 10. Mankoff DA, Bellon JR. Positron-emission tomographic imaging of cancer: glucose metabolism and beyond. Semin Radiat Oncol. 2001 Jan;11(1):16-27. [PUBMED]
  • 11. Pan JG, Mak TW. Metabolic targeting as an anticancer strategy: dawn of a new era? Sci STKE. 2007 Apr 10;2007(381):pe14. [PUBMED]